Abu Dhabi
Abu Dhabi Islamic Bank (ADIB) has launched a second tranche of its Healthcare Pharmaceuticals Equities Basket Note following popular demand from customers and investors on the first tranche that was launched in May 2017. Designed to capitalise on projected growth in the health care industry, the Sharia-compliant note matures in one year and provides 100 per cent capital protection at maturity to minimise investment risk.
The product provides investors with exposure to a basket of leading international companies operating across the health care and pharmaceutical sectors, including Pfizer, Merck, Celgene, Novartis and Novo Nordisk. The note is open for subscription until August 24, 2017 and offers a 3-month lock-in period. The minimum investment for the note, which has a maturity date of August 30, 2018, is US$30,000.
